Type of publications
Regions
Countries
Diseases
Publication date

Comorbidities' potential impacts on severe and non-severe patients with COVID-19: A systematic review and meta-analysis

Rating : Critically low
Risk factor All age groups China COVID-19
Published: 2021

Comparison of comorbidities in relation to critical conditions among coronavirus disease 2019 patients: A network meta-analysis

Rating : Critically low
Risk factor Adults (18+) Elderly (65+) China COVID-19
Published: 2021

Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors

Rating : Critically low
Risk factor All age groups China COVID-19
Published: 2021

Review influenza vaccine effectiveness in mainland china: A systematic review and meta-analysis

Rating : Critically low
Efficacy/effectiveness All age groups China Influenza
Published: 2021

ATAGI Guidance on Myocarditis and Pericarditis after mRNA COVID-19 vaccines - 9 August 2021

mRNA vaccines Recommendation Australia COVID-19
Download:
Published: 2021 Author: ATAGI

Statement on the Clinical use of Zoster vaccine in older adults in Australia - 8 July 2021

Recommendation Australia Herpes zoster
Download:
Published: 2021 Author: ATAGI

ATAGI advice on seasonal influenza vaccines in 2021 - 8 June 2021

Recommendation Australia Influenza COVID-19
Download:
Published: 2021 Author: ATAGI

ATAGI Annual Statement on Immunisation 2021 - 24 May 2021

immunization strategy Recommendation Australia
Download:
Published: 2021 Author: ATAGI

Joint statement on COVID-19 AstraZeneca vaccine advice from ATAGI - 20 May, 2021

AstraZeneca COVID-19 vaccine Recommendation Australia COVID-19
Download:
Published: 2021 Author: ATAGI

COVID-19 vaccination : ATAGI decision guide for people receiving palliative care or end-of-life care - 4 May 2021

Recommendation Australia COVID-19
Download:
Published: 2021 Author: ATAGI